Most rheumatoid arthritis patients are satisfied with their rheumatoid arthritis treatment, experts write in Arthritis & Rheumatism.

Read full story

CombinatoRx Inc. said Thursday it abandoned a potential drug to treat rheumatoid arthritis after clinical trials showed it did not significantly decrease inflammation.

Read full story

Toyama Chemical Co., Ltd. and Roche announced recently that they have entered into a licensing agreement forthe worldwide research, development and commercialization of Toyama Chemical’s novel oral rheumatoid arthritis agent T-5224. By inhibiting a specific inflammatory process, T-5224 has the potential to block signs and symptoms of rheumatoid arthritis as well as the progressive destruction of …

Read full story

Simple tasks of daily life get harder for people with arthritis. But a wide range of treatments means there’s probably something to make you feel better.

Read full story